Alys Pharmaceuticals
Boston
About Alys Pharmaceuticals
Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape through advanced scientific innovations and a strong research and development-focused multi-platform pipeline. Alys emerged as a result of the strategic aggregation of 6 asset-centric companies backed by Medicxi.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $100.0M
- Funding stage: Seed
- Last round: Seed (Feb 2024)
- Website: alyspharma.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/alys-pharmaceuticals-125922 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.